After the flood: BCG recall and ImmuCyst halt

Following a flood at Sanofi Pasteur's Connaught Campus facility in Toronto last October, the company has issued a voluntary recall of its BCG vaccine in Canada, Australia and New Zealand. It has also halted all distribution of its BCG-based bladder cancer product ImmuCyst/TheraCys, which is manufactured in the same building and licensed in about 50 countries.

Following a flood at Sanofi Pasteur's Connaught Campus facility in Toronto last October, the company has issued a voluntary recall of its BCG vaccine in Canada, Australia and New Zealand. It has also halted all distribution of its BCG-based bladder cancer product ImmuCyst/TheraCys, which is manufactured in the same building and licensed in about 50 countries.

The company says it halted supply of ImmuCyst/TheraCys on 26 April, but patient advocacy websites contain posts from patients experiencing...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Anticancer

More from Therapeutic Category